[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.153.63. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
December 1982

Vitrectomy in Ocular Toxocariasis

Author Affiliations

From the Francis I. Proctor Foundation for Research in Ophthalmology (Drs Belmont and O'Connor), the Department of Ophthalmology (Drs Irvine and Belmont), University of California, San Francisco; the Division of Ophthalmology, Scripps Clinic and Hospital, La Jolla, Calif (Dr Belmont); and the Retina Service of Wills Eye Hospital and Thomas Jefferson University, Philadelphia (Dr Benson). Dr Belmont is now with the Wills Eye Hospital.

Arch Ophthalmol. 1982;100(12):1912-1915. doi:10.1001/archopht.1982.01030040892004
Abstract

• Subtotal pars plana vitrectomy was performed in four patients with chronic toxocaral endophthalmitis. In two instances, chronic intraocular inflammation proved unresponsive to intensive corticosteroid therapy, but improved dramatically following vitrectomy. In one patient, a dense retrolenticular membrane was removed, and intractable amblyopia was prevented. Vitrectomy relieved vitreoretinal traction involving the macula in two instances and cured a peripheral traction retinal detachment in a third. Information gleaned from these cases suggests new guidelines for the laboratory confirmation of ocular toxocariasis. Patients with toxocaral endophthalmitis may benefit from pars plana vitrectomy when chronic inflammation does not respond to medical measures or when such inflammation causes permanent structural changes that threaten or interfere with central vision.

×